Sir, Enterobacteriaceae producing metallo-b-lactamases (MBLs), and particularly VIM-type MBLs, have frequently been implicated in hospital outbreaks across Europe, 1 bla VIM genes having been linked to Tn402 derivatives, epidemic plasmids (IncN, IncI1, IncHI2) and occasionally with particular Enterobacteriaceae clones. 1 -4 VIM enzymes have been classified in three clusters (VIM-1, VIM-2 and VIM-7) according to their amino acid sequences (http://www.lahey.org/ studies), VIM-1 and VIM-2 being the most widespread variants. 5 In this study, we report the molecular epidemiology and the antibiotic susceptibility profiles of Klebsiella pneumoniae clinical isolates producing VIM-34, a novel VIM-1 variant identified in Portugal.
In October 2011 and October 2012, two K. pneumoniae isolates (strains K43 and K47, respectively) showing reduced susceptibility to carbapenems (MICs 0.38-1.0 mg/L) were recovered from urine samples of hospitalized patients in a general hospital in northern Portugal (Hospital Pedro Hispano). They are the only carbapenemase-producing Enterobacteriaceae isolates identified in this hospital since the beginning of 2011, when reference protocols for carbapenemase detection were adopted.
Antimicrobial susceptibility tests were performed using the Etest for b-lactams and disc diffusion for all other antimicrobial agents. These showed that all isolates were resistant to diverse cephalosporins, aztreonam, b-lactam/b-lactamase inhibitor combinations (Table 1) , nalidixic acid, ciprofloxacin, chloramphenicol, gentamicin, kanamycin, netilmicin, streptomycin, tobramycin and sulphonamides, but susceptible to trimethoprim and amikacin (http://www.eucast.org/). 6 Standard disc diffusion phenotypic tests using different b-lactams and b-lactamase inhibitors (cefotaxime, ceftazidime, imipenem; 0.2 mM EDTA, clavulanic acid), 6 isoelectric focusing, PCR and sequencing 7 demonstrated the production of VIM-34 (pI¼ 5.4) (GenBank accession number JX013656), a novel VIM-type enzyme differing from VIM-1 by one amino acid change (V113I, according to MBL standard numbering scheme) and co-production of SHV-1 (pI¼ 7.6) and SHV-12 (pI¼ 8.2) extended-spectrum b-lactamase. We could not identify the origin of these isolates but as both patients had multiple previous hospitalizations (including in other hospitals) and carried the same novel bla VIM type, a common nosocomial source seems more plausible than community acquisition.
The bla VIM-34 from the K47 isolate was cloned in the pBGS18 (kanamycin resistance) plasmid using primers VIM-EcoRI (5 ′ -GGGAATT CGCAGTCGCCCTAAAACAAAG-3 ′ ) and VIM-PstI (5 ′ -AACTGCAGCCGCTCCA ACGATTTGTTAT-3 ′ ) (restriction sites are underlined), and the expression vector (pBGS18/VIM-34) was further introduced into Escherichia coli DH5a, as previously reported. 8 MICs of different b-lactams were determined using the Etest (in triplicate) and compared with those corresponding to a bla VIM-1 -carrying clone obtained in the same conditions (Table 1 ). The VIM-34-producing E. coli recombinant yielded b-lactam MIC values similar to those observed in the VIM-1-encoding transformant (with the exception of cefoxitin; Table 1 ). Because our experiments were performed in an isogenic context and identical standard experimental conditions, we are able to hypothesize that the substitution V113I has a low influence on the MICs of carbapenems, although further studies of enzymatic activity are required to confirm this observation.
The isolates exhibited identical XbaI-PFGE profiles and clonal identification by multilocus sequence typing (http://www.pasteur.fr/ recherche/genopole/PF8/mlst/Kpneumoniae.html) revealed that they belong to the intercontinental ST15 K. pneumoniae clone, widely disseminated in different European countries and associated with the spread of extended-spectrum b-lactamases (CTX-M-15; diverse SHV types) and/or MBLs (VIM-1, NDM-1).
2,3,7,9,10 Conjugation assays performed by broth and/or filter mating methods using E. coli HB101 (azide and kanamycin resistant, Lac-, plasmid free) as recipient at 228C and 378C (selection of transconjugants in MacConkey agar with 2 mg/L of ceftazidime and 130 mg/L of azide) 7 failed to yield transconjugants either for bla VIM-34 or bla SHV-12 . The location of bla (bla VIM-34 , bla SHV-12 ) genes and plasmid characterization were accomplished by S1-and I-CeuI-PFGE, and identification of incompatibility groups. 7 In both isolates, bla VIM-34 , bla SHV-12 and repHI2 probes hybridized in the same chromosomal band (I-CeuI-PFGE) whereas no signals were observed in the S1 gel, suggesting the acquisition of both bla genes by an IncHI2 plasmid and subsequent plasmid (whole or in part) integration. A chromosomal location for bla genes, including bla VIM , has been occasionally observed in different Enterobacteriaceae species. 1 The linkage of bla VIM-34 to class 1 integrons and Tn402 derivatives was investigated by PCR (intI1, 5 ′ CS-3 ′ CS region, orf5, orf6, IS1326, IS1353, IS6100) and sequencing.
4,11 bla VIM-34 was located within an 6 kb class 1 integron named In817 by INTE-GRALL (http://integrall.bio.ua.pt/) (GenBank accession number JX185132), with an original array of gene cassettes comprising bla VIM-34 , aacA4
′ , aphA15, aadA1b and catB2 ( Figure S1 ; available as Supplementary data at JAC Online). The absence of tni 402 sequences and the high similarity detected with In70 and In113, identified in VIM-1-producing Achromobacter xylosoxidans, K. pneumoniae and E. coli isolates, suggests that the In817 integron might have arisen by both recombination and in vivo evolution events ( Figure S1 ; available as Supplementary data at JAC Online). 4 In summary, we present the first report of VIM-34, a VIM-1-like variant embedded in the novel integron type In817 on the chromosome of the intercontinental ST15 K. pneumoniae clone, associated with carbapenem susceptibility profiles similar to those observed for VIM-1. This study highlights the risk of further dissemination of the multidrug-resistant ST15 K. pneumoniae clone and genetic backgrounds containing metallo-b-lactamase genes in our country, which deserves future monitoring.
